|
ANKRD36 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.017900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.549940E-02 |
| Normal-vs-Stage2 |
1.063190E-01 |
| Normal-vs-Stage3 |
5.573200E-01 |
| Normal-vs-Stage4 |
3.960400E-01 |
| Stage1-vs-Stage2 |
4.903000E-01 |
| Stage1-vs-Stage3 |
3.251900E-02 |
| Stage1-vs-Stage4 |
9.708400E-01 |
| Stage2-vs-Stage3 |
1.593650E-01 |
| Stage2-vs-Stage4 |
6.756600E-01 |
| Stage3-vs-Stage4 |
5.126000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.314000E-02 |
| Normal-vs-AfricanAmerican |
1.495690E-02 |
| Normal-vs-Asian |
4.559600E-01 |
| Caucasian-vs-AfricanAmerican |
5.247800E-01 |
| Caucasian-vs-Asian |
7.761800E-01 |
| AfricanAmerican-vs-Asian |
6.704200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.702100E-02 |
| Normal-vs-Female |
5.964300E-03 |
| Male-vs-Female |
2.927600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.201400E-01 |
| Normal-vs-Extreme_Weight |
5.209700E-02 |
| Normal-vs-Obese |
1.286350E-02 |
| Normal-vs-Extreme_Obese |
4.156200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.337000E-01 |
| Normal_Weight-vs-Obese |
4.253200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.074800E-01 |
| Extreme_Weight-vs-Obese |
4.385000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.777200E-01 |
| Obese-vs-Extreme_Obese |
2.024200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.270300E-02 |
| Normal-vs-Age(41-60Yrs) |
7.020500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.154170E-01 |
| Normal-vs-Age(81-100Yrs) |
7.158600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.693400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.445450E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.179990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.237800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.115760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.601800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.235600E-04 |
| Normal-VS-Type2 PRCC |
9.159600E-01 |
| Normal-VS-KIRP CIMP |
4.451700E-02 |
| Normal-VS-Unclassified PRCC |
4.127700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.78799999997581E-06 |
| Type1 PRCC-VS-KIRP CIMP |
8.904600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.021200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.720400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.429700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.678800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.008400E-01 |
| Normal-vs-N1 |
8.789500E-02 |
| Normal-vs-N2 |
5.346200E-01 |
| N0-vs-N1 |
2.397400E-01 |
| N0-vs-N2 |
8.567600E-01 |
| N1-vs-N2 |
6.879400E-01 |
|
|
